Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Strengthening health systems through surgeryThe Lancet (British edition), 2024-06, Vol.403 (10442), p.2358-2360 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)01031-6 ;PMID: 38782001Full text available |
|
2 |
Material Type: Article
|
The scope of the antimicrobial resistance challengeThe Lancet (British edition), 2024-06, Vol.403 (10442), p.2426-2438 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00876-6 ;PMID: 38797176Full text available |
|
3 |
Material Type: Article
|
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysisThe Lancet (British edition), 2024-06, Vol.403 (10442), p.2439-2454 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Published by Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00862-6 ;PMID: 38797180Full text available |
|
4 |
Material Type: Article
|
Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trialThe Lancet (British edition), 2024-06, Vol.403 (10442), p.2395-2404 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00702-5 ;PMID: 38761811Full text available |
|
5 |
Material Type: Article
|
Systemic lupus erythematosusThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2326-2338 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00398-2 ;PMID: 38642569Full text available |
|
6 |
Material Type: Article
|
Cyberattacks on health care—a growing threatThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2263-2263 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)01074-2 ;PMID: 38796195Full text available |
|
7 |
Material Type: Article
|
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2293-2306 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00184-3 ;PMID: 38705160Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Why not eliminate HTLV-1 while eliminating HIV-1?The Lancet (British edition), 2024-05, Vol.403 (10441), p.2288-2289 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00295-2 ;PMID: 38796201Full text available |
|
9 |
Material Type: Article
|
Centring equity in the response to chronic suppurative otitis mediaThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2269-2272 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00698-6 ;PMID: 38621396Full text available |
|
10 |
Material Type: Article
|
Chronic suppurative otitis mediaThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2339-2348 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00259-9 ;PMID: 38621397Full text available |
|
11 |
Material Type: Article
|
Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa – Authors' replyThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2292-2292 [Peer Reviewed Journal]2024 ;Copyright Elsevier Limited May 25, 2024 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00633-0 ;PMID: 38796207Full text available |
|
12 |
Material Type: Article
|
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on ImmunizationThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2307-2316 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00850-X ;PMID: 38705159Full text available |
|
13 |
Material Type: Article
|
Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trialThe Lancet (British edition), 2024-05 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00538-5 ;PMID: 38782004Full text available |
|
14 |
Material Type: Article
|
3 years after the Myanmar military coup—the people are sufferingThe Lancet (British edition), 2024-05, Vol.403 (10440), p.1966-1969 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00584-1 ;PMID: 38555925Full text available |
|
15 |
Material Type: Article
|
Totality of evidence refutes neoplasm risk with fezolinetantThe Lancet (British edition), 2024-05, Vol.403 (10440), p.1987-1988 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00709-8 ;PMID: 38762322Full text available |
|
16 |
Material Type: Article
|
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021The Lancet (British edition), 2024-05, Vol.403 (10440), p.2204-2256 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00685-8 ;PMID: 38762325Full text available |
|
17 |
Material Type: Article
|
Global Burden of Disease Study 2021 estimates: implications for health policy and researchThe Lancet (British edition), 2024-05, Vol.403 (10440), p.1958-1959 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00812-2 ;PMID: 38642567Full text available |
|
18 |
Material Type: Article
|
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet (British edition), 2024-05, Vol.403 (10440), p.2133-2161 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00757-8 ;PMID: 38642570Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Totality of evidence refutes neoplasm risk with fezolinetant – Authors' replyThe Lancet (British edition), 2024-05, Vol.403 (10440), p.1988-1988 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00708-6 ;PMID: 38762323Full text available |
|
20 |
Material Type: Article
|
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet (British edition), 2024-05, Vol.403 (10440), p.2100-2132 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2024 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00367-2 ;PMID: 38582094Digital Resources/Online E-Resources |